ASN Kidney Week Poster Highlights
By Roger Rodby, MD, Edgar Lerma, MD, Joel M. Topf, MD, FACP - Last Updated: November 11, 2024Roger Rodby, MD, and Edgar Lerma, MD, led a tour of ASN Kidney Week posters on October 24, 2024. Afterward, they joined Joel Topf, MD, to discuss a few of the highlights.
Advertisement
Post Tags:Nephrology Videos
Advertisement
Related Posts
Obinutuzumab reduced proteinuria in patients with FSGS who were treatment-resistant or on immunosuppressive therapy.
RGLS8429 increases urinary PC1 and PC2 proteins, which may help reduce height-adjusted total kidney volume in ADPKD.
Researchers evaluated the efficacy of sparsentan in a subset of patients with genetic focal segmental glomerulosclerosis.
Could pravastatin slow the rate of increase in height-adjusted total kidney volume in adults with ADPKD?
A study examined the efficacy of adding SZC to allow patients with stage 3-4 DKD to maintain treatment with RAASi.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.